Neurotensin Signaling Activates MicroRNAs-21 and-155 and Akt, Promotes Tumor Growth in Mice, and Is Increased in Human Colon Tumors

被引:160
作者
Bakirtzi, Kyriaki [1 ]
Hatziapostolou, Maria [2 ,3 ]
Karagiannides, Iordanes [1 ]
Polytarchou, Christos [4 ]
Jaeger, Savina [5 ]
Iliopoulos, Dimitrios [2 ,3 ]
Pothoulakis, Charalabos [1 ]
机构
[1] Univ Calif Los Angeles, Div Digest Dis, Ctr Inflammatory Bowel Dis, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[4] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA USA
[5] Novartis Inst Biomed Res, Dept Dev Mol Pathways, Cambridge, MA USA
关键词
Neuropeptide; Colorectal Cancer; Signal Transduction; Tumor Suppressor; INFLAMMATORY-BOWEL-DISEASE; PROTEIN-KINASE-B; CANCER-CELLS; GASTRIC-CANCER; TARGET GENES; MAP-KINASE; EXPRESSION; IDENTIFICATION; PATHWAY; RAT;
D O I
10.1053/j.gastro.2011.07.038
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
BACKGROUND & AIMS: Neurotensin promotes inflammation and colon cancer via the neurotensin-1 receptor (NTR1). MicroRNAs (miR) regulate protein synthesis by degrading or preventing translation of mRNAs. We analyzed expression of 365 different microRNAs by human colonic epithelial cells (NCM460) after activation of NTR1. METHODS: We performed microarray analysis of mRNA expression by neurotensin-stimulated NCM460 cells that overexpressed NTR1. Nuclear factor-kappa B (NF-kappa B) binding sites were identified and tumorigenesis was assessed using soft agar assays and xenograft analysis of severe combined immunodeficiency mice. Targets of neurotensin-regulated microRNAs were identified via bioinformatic, real-time polymerase chain reaction, and immunoblot analyses. We analyzed RNA samples from human normal colon and tumor samples. RESULTS: Neurotensin stimulated differential expression of 38 microRNAs, including miR-21 and miR-155, which have been associated with tumor growth and contain NF-kappa B binding sites. Neurotensin expression increased colony formation by HCT-116 cells. Blocking miR-21 and/or miR-155 prevented colony formation (P<.001). In mice, intraperitoneal administration of neurotensin increased the growth rate of HCT-116 xenograft tumors; blocking miR-21 and/or miR-155 slowed this tumor growth. Neurotensin activated Akt in HCT-116 cells; this effect was inhibited by blocking miR-21 and/or miR-155 (P<.001). Neurotensin activated AKT through miR-155-mediated suppression of the phosphatase protein phosphatase 2A catalytic subunit alpha (PPP2CA). Levels of phosphatase and tensin homolog (PTEN) and suppressor of cytokine signaling 1 (SOCS1) mRNA, potential targets of miR-21 and miR-155, respectively, were down-regulated by these miRs. Levels of NTR1, miR-21, and miR-155 increased significantly in human colon tumor samples, compared with normal tissues, whereas PPP2CA, SOCS1, and PTEN mRNAs were reduced significantly. CONCLUSIONS: NTR1 activation stimulates expression of miR-21 and miR-155 in colonocytes, via Akt and NF-kappa B, to down-regulate PTEN and SOCS1 and promote growth of tumors in mice. Levels of NTR1, miR-21, and miR-155 increase in human colon tumor samples and correlate with tumor stage.
引用
收藏
页码:1749 / U311
页数:14
相关论文
共 51 条
[1]
let-7 microRNA functions as a potential growth suppressor in human colon cancer cells [J].
Akao, Yukihiro ;
Nakagawa, Yoshihito ;
Naoe, Tomoki .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2006, 29 (05) :903-906
[2]
MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[3]
Over-expression of neurotensin high-affinity receptor 1 (NTS1) in relation with its ligand neurotensin (NT) and nuclear β-catenin in inflammatory bowel disease-related oncogenesis [J].
Bossard, Celine ;
Souaze, Frederique ;
Jarry, Anne ;
Bezieau, Stephane ;
Mosnier, Jean-Francois ;
Forgez, Patricia ;
Laboisse, Christian L. .
PEPTIDES, 2007, 28 (10) :2030-2035
[4]
Neuropeptide neurotensin stimulates intestinal wound healing following chronic intestinal inflammation [J].
Brun, P ;
Mastrotto, C ;
Beggiao, E ;
Stefani, A ;
Barzon, L ;
Sturniolo, GC ;
Palù, G ;
Castagliuolo, I .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2005, 288 (04) :G621-G629
[5]
CARRAWAY R, 1976, J BIOL CHEM, V251, P7045
[6]
CARRAWAY R, 1973, J BIOL CHEM, V248, P6854
[7]
A neurotensin antagonist, SR 48692, inhibits colonic responses to immobilization stress in rats [J].
Castagliuolo, I ;
Leeman, SE ;
BartolakSuki, E ;
Nikulasson, S ;
Qiu, BS ;
Carraway, RE ;
Pothoulakis, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (22) :12611-12615
[8]
Neurotensin is a proinflammatory neuropeptide in colonic inflammation [J].
Castagliuolo, I ;
Wang, CC ;
Valenick, L ;
Pasha, A ;
Nikulasson, S ;
Carraway, RE ;
Pothoulakis, C .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (06) :843-849
[9]
Gastrointestinal hormone receptors in primary human colorectal carcinomas (vol 129, pg 313, 2005) [J].
Dr. Chao ;
Dr. Tallman ;
Dr. Ives ;
Dr. Townsend, Jr. ;
Dr. Hellmich .
JOURNAL OF SURGICAL RESEARCH, 2006, 134 (02) :363-363
[10]
NEUROTENSIN EXPRESSION AND RELEASE IN HUMAN COLON CANCERS [J].
EVERS, BM ;
ISHIZUKA, J ;
CHUNG, DH ;
TOWNSEND, CM ;
THOMPSON, JC .
ANNALS OF SURGERY, 1992, 216 (04) :423-431